192 related articles for article (PubMed ID: 32529678)
21. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
[TBL] [Abstract][Full Text] [Related]
22. Decoding the LncRNA transcriptome of esophageal cancer: identification of clinically relevant LncRNAs.
Khadirnaikar S; Narayanan SP; Shukla SK
Biomark Med; 2018 Oct; 12(10):1083-1093. PubMed ID: 30191740
[TBL] [Abstract][Full Text] [Related]
23. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor.
Zheng H; Li BH; Liu C; Jia L; Liu FT
Biomed Res Int; 2020; 2020():4951692. PubMed ID: 32149111
[TBL] [Abstract][Full Text] [Related]
25. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
26. Non-coding RNA profile in lung cancer.
Ghafouri-Fard S; Shoorei H; Branicki W; Taheri M
Exp Mol Pathol; 2020 Jun; 114():104411. PubMed ID: 32112788
[TBL] [Abstract][Full Text] [Related]
27. Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer.
Hou X; Wen J; Ren Z; Zhang G
Oncotarget; 2017 Jun; 8(26):43571-43578. PubMed ID: 28388588
[TBL] [Abstract][Full Text] [Related]
28. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
Xu Y; Chen J; Yang Z; Xu L
Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis.
Aftabi Y; Ansarin K; Shanehbandi D; Khalili M; Seyedrezazadeh E; Rahbarnia L; Asadi M; Amiri-Sadeghan A; Zafari V; Eyvazi S; Bakhtiyari N; Zarredar H
IUBMB Life; 2021 Feb; 73(2):307-327. PubMed ID: 33369006
[TBL] [Abstract][Full Text] [Related]
30. AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis.
Zeng Z; Bo H; Gong Z; Lian Y; Li X; Li X; Zhang W; Deng H; Zhou M; Peng S; Li G; Xiong W
Tumour Biol; 2016 Jan; 37(1):729-37. PubMed ID: 26245991
[TBL] [Abstract][Full Text] [Related]
31. A genome-wide analysis of long noncoding RNA profile identifies differentially expressed lncRNAs associated with Esophageal cancer.
Liu W; Zhang Y; Chen M; Shi L; Xu L; Zou X
Cancer Med; 2018 Aug; 7(8):4181-4189. PubMed ID: 29926523
[TBL] [Abstract][Full Text] [Related]
32. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH
Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401
[TBL] [Abstract][Full Text] [Related]
34. Advances in esophageal cancer: A new perspective on pathogenesis associated with long non-coding RNAs.
Huang X; Zhou X; Hu Q; Sun B; Deng M; Qi X; Lü M
Cancer Lett; 2018 Jan; 413():94-101. PubMed ID: 29104147
[TBL] [Abstract][Full Text] [Related]
35. The emerging role of long noncoding RNAs in esophageal carcinoma: from underlying mechanisms to clinical implications.
Luan S; Yang Y; Zhou Y; Zeng X; Xiao X; Liu B; Yuan Y
Cell Mol Life Sci; 2021 Apr; 78(7):3403-3422. PubMed ID: 33464385
[TBL] [Abstract][Full Text] [Related]
36. Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis.
Qin S; Gao Y; Yang Y; Zhang L; Zhang T; Yu J; Shi C
Gynecol Obstet Invest; 2019; 84(4):350-359. PubMed ID: 30625468
[TBL] [Abstract][Full Text] [Related]
37. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway.
Wang X; Gao Z; Liao J; Shang M; Li X; Yin L; Pu Y; Liu R
J Toxicol Environ Health A; 2016; 79(9-10):407-18. PubMed ID: 27267823
[TBL] [Abstract][Full Text] [Related]
38. Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.
Luo R; Song J; Zhang W; Ran L
Dig Dis Sci; 2020 Dec; 65(12):3538-3550. PubMed ID: 31960204
[TBL] [Abstract][Full Text] [Related]
39. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
[TBL] [Abstract][Full Text] [Related]
40. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.
Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
